Beneficial effects of tumour necrosis factor-alpha (TNF-alpha) blockade in rheumatoid arthritis (RA) (Q40467512)

20 September 2017

1 reference

title

Beneficial effects of tumour necrosis factor-alpha (TNF-alpha) blockade in rheumatoid arthritis (RA) (English)

1 reference

20 September 2017

0 references

1 reference

Maini RN

1

1 reference

20 September 2017

Elliott MJ

series ordinal

2

1 reference

20 September 2017

Brennan FM

series ordinal

3

1 reference

20 September 2017

Feldmann M

series ordinal

4

1 reference

20 September 2017

1 August 1995

1 reference

Clinical and Experimental Immunology

20 September 2017

1 reference

20 September 2017

101

1 reference

20 September 2017

2

1 reference

20 September 2017

207-212

1 reference

Long-term outcome of treating rheumatoid arthritis: results after 20 years

20 September 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.1995.TB08340.X

Factors predicting a poor life prognosis in rheumatoid arthritis: an eight year prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.1995.TB08340.X

New directions for biological therapy in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.1995.TB08340.X

TNF alpha--a pivotal role in rheumatoid arthritis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.1995.TB08340.X

Detection of interleukin 8 biological activity in synovial fluids from patients with rheumatoid arthritis and production of interleukin 8 mRNA by isolated synovial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.1995.TB08340.X

Detection of transforming growth factor-beta in rheumatoid arthritis synovial tissue: lack of effect on spontaneous cytokine production in joint cell cultures

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.1995.TB08340.X

Immunoregulatory role of interleukin 10 in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.1995.TB08340.X

Inhibitory effect of TNF alpha antibodies on synovial cell interleukin-1 production in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.1995.TB08340.X

Localization of tumor necrosis factor receptors in the synovial tissue and cartilage-pannus junction in patients with rheumatoid arthritis. Implications for local actions of tumor necrosis factor alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.1995.TB08340.X

Anti-tumor necrosis factor ameliorates joint disease in murine collagen-induced arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.1995.TB08340.X

Construction and initial characterization of a mouse-human chimeric anti-TNF antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.1995.TB08340.X

Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor α

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.1995.TB08340.X

Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor alpha (cA2) versus placebo in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.1995.TB08340.X

Repeated therapy with monoclonal antibody to tumour necrosis factor alpha (cA2) in patients with rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.1995.TB08340.X

Immunological intervention reveals reciprocal roles for tumor necrosis factor-alpha and interleukin-10 in rheumatoid arthritis and systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.1995.TB08340.X

Monoclonal anti‐TNFα Antibody as a Probe of Pathogenesis and Therapy of Rheumatoid Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.1995.TB08340.X

Laboratory testing on cerebrospinal fluid. A reappraisal.

21 January 2018

1 reference

12 December 2020

Excessive production of interleukin 6/B cell stimulatory factor-2 in rheumatoid arthritis

1 reference

12 December 2020

Interleukin-1 and tumour necrosis factor mRNA expression in rheumatoid arthritis: prolonged production of IL-1 alpha

1 reference

12 December 2020

Expression of granulocyte-macrophage colony-stimulating factor in rheumatoid arthritis: regulation by tumor necrosis factor-alpha

1 reference

12 December 2020

Localization of tumor necrosis factor alpha in synovial tissues and at the cartilage-pannus junction in patients with rheumatoid arthritis

1 reference

12 December 2020

Transgenic mice expressing human tumour necrosis factor: a predictive genetic model of arthritis

1 reference

12 December 2020

Acceleration of onset of collagen-induced arthritis by intra-articular injection of tumour necrosis factor or transforming growth factor-beta

1 reference

12 December 2020

Increased levels of soluble tumor necrosis factor receptors in the sera and synovial fluid of patients with rheumatic diseases

1 reference

12 December 2020

Successful therapy of collagen-induced arthritis with TNF receptor-IgG fusion protein and combination with anti-CD4

1 reference

12 December 2020

10.1111/J.1365-2249.1995.TB08340.X

Identifiers

DOI

1 reference

20 September 2017

0 references

1 reference